Cardioverter-Defibrillator

Sudden Death in Cardiomyopathy Reduced With ICD Treatment

Sudden Death in Cardiomyopathy Reduced With ICD Treatment

ICD therapy reduced the incidence of sudden and all-cause mortality in comparison to conventional care for ischemic or nonischemic cardiomyopathy.

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

By

Long-detection programming improved survival, decreased the likelihood of hospitalization, and reduced therapy in patients with single-chamber ICDs.

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

Implantable Cardioverter-Defibrillators, Pacemakers Can Receive MRI

None of the patients had device failure during the MRI; however, 6 patients did have atrial fibrillation or flutter but each case stopped on its own.

Implantable Cardioverter Defibrillator Shock-Related Healthcare Utilization Trends

Implantable Cardioverter Defibrillator Shock-Related Healthcare Utilization Trends

Nearly half of all implantable cardioverter defibrillator shock events utilized health care.

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Cardiac resynchronization therapy with defibrillation correlated with reduced hospitalization or all-cause mortality and all-cause mortality in advanced systolic heart failure.

ICDs Rarely Affected by Smartphone Electromagnetic Interference

ICDs Rarely Affected by Smartphone Electromagnetic Interference

By

Of 307 patients, only 1 patient's ICD had electromagnetic interference produced by a telephone.

Outcomes of Implantable Cardioverter-Defibrillators for Secondary Prevention

Outcomes of Implantable Cardioverter-Defibrillators for Secondary Prevention

By

In older adults who received implantable cardioverter-defibrillators as secondary prevention of sudden cardiac death, the risk of death was 21.8%.

FDA Issues Cybersecurity Alert for St. Jude Medical ICDs

FDA Issues Cybersecurity Alert for St. Jude Medical ICDs

By

St. Jude Medical implantable cardiac devices and the Merlin@home Transmitter may be vulnerable to cybersecurity attacks.

Using Wearable Cardioverter Defibrillators After Explantation of ICDs

Using Wearable Cardioverter Defibrillators After Explantation of ICDs

By

Researchers conducted a study to determine the risk of VT/VF using wearable cardioverter defibrillators after ICD explantation.

Transvenous vs Subcutaneous Implantable Cardioverter-Defibrillators

Transvenous vs Subcutaneous Implantable Cardioverter-Defibrillators

Complication rates were 13.7% and 18.0%, respectively, in the subcutaneous ICD and transvenous ICD groups and infection rates were 4.1% vs 3.6%.

Should Anticoagulation Be Given in Afib/Atrial Tachycardia With ICDs?

Should Anticoagulation Be Given in Afib/Atrial Tachycardia With ICDs?

By

Anticoagulation therapy may not reduce stroke risk for patients with ICDs who have only brief episodes of AT or AF.

FDA: ICD and CRT-D Batteries May Prematurely Fail

FDA: ICD and CRT-D Batteries May Prematurely Fail

By

Implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators manufactured by St. Jude Medical may have batteries that will prematurely deplete.

Bridge-to-Recovery Strategies in LVAD Implantation

Bridge-to-Recovery Strategies in LVAD Implantation

By

Cardiac recovery was independently predicted by age, nonischemic cardiomyopathy, time from cardiac diagnosis, lack of ICD, serum creatinine levels, and LV end-diastolic dimensions.

Lead Abandonment Outcomes in Patients With Cardiac Devices

Lead Abandonment Outcomes in Patients With Cardiac Devices

By

Previously abandoned leads were associated with more complications from infection.

Is Exercise Safe for Patients With Heart Failure With ICDs?

Is Exercise Safe for Patients With Heart Failure With ICDs?

By

Safety and efficacy of exercise training in patients with heart failure with implantable cardioverter defibrillators.

ICD Implantation in Nonischemic Heart Failure Does Not Reduce Long-Term Mortality

ICD Implantation in Nonischemic Heart Failure Does Not Reduce Long-Term Mortality

By

Of the 556 patients assigned to receive an ICD, 120 died compared with 131 in the control group who received usual care.

Updated Analyses and Insights from Cardiac Resynchronization Therapy Clinical Trial

Updated Analyses and Insights from Cardiac Resynchronization Therapy Clinical Trial

By

Updated analyses and insights from the first cardiac resynchronization therapy-heart failure mortality/morbidity trial comparing defibrillator or pacemaker with pharmacologic therapy alone.

Catheter Ablation vs Antiarrhythmic Drug Escalation Therapy in Patients With Ventricular Tachycardia

Catheter Ablation vs Antiarrhythmic Drug Escalation Therapy in Patients With Ventricular Tachycardia

By

The catheter ablation group experienced a significantly lower rate of the primary outcome compared with the escalated therapy group.

Cardiac Resynchronization Therapy Devices Have Higher Rate of Complications

Cardiac Resynchronization Therapy Devices Have Higher Rate of Complications

Researchers analyzed the performance of 3 types of implantable cardioverter-defibrillators: single-chamber, dual-chamber, and cardiac resynchronization therapy devices.

Biventricular Pacing Superior to Right Ventricular Pacing in Patients With Atrioventricular Block

Biventricular Pacing Superior to Right Ventricular Pacing in Patients With Atrioventricular Block

By

The biventricular pacing arm showed greater improvement in New York Heart Association functional class at 12 months.

Lack of Anticoagulation During Cardioversion Increases Risk of Thromboembolic Complications

Lack of Anticoagulation During Cardioversion Increases Risk of Thromboembolic Complications

By

Risk of thromboembolic complications was 5 times higher among patients without therapeutic anticoagulation during cardioversion.

Atrial Fibrillation Associated With Decline in Physical Activity in Older Adults

Atrial Fibrillation Associated With Decline in Physical Activity in Older Adults

By

Two studies suggest that atrial fibrillation results in reduced physical activity among older adults.

Statewide Initiatives Improved Out-of-Hospital Cardiac Arrest Care and Outcomes

Statewide Initiatives Improved Out-of-Hospital Cardiac Arrest Care and Outcomes

By

Results indicated that the rate of patients who received bystander CPR increased at home and in public first-responder defibrillation increased at home but not in public.

American Heart Association Issues Wearable Cardioverter-Defibrillator Recommendations

American Heart Association Issues Wearable Cardioverter-Defibrillator Recommendations

Wearable cardioverter-defibrillators are reasonable bridges to more "definitive therapy" or in situations associated with increased risk of death in which implantable defibrillators reduce sudden cardiac death but not overall survival.

Few Patients Know Implanatable Cardioverter Defibrillators Can Be Deactivated

Few Patients Know Implanatable Cardioverter Defibrillators Can Be Deactivated

Few patients with implantable cardioverter defibrillators are aware that they can deactivate their devices in their final days to avoid painful shocks.

Possible Mechanisms Behind Implantable Cardioverter Defibrillator Lead Malfunctions After LVAD Implantation

Possible Mechanisms Behind Implantable Cardioverter Defibrillator Lead Malfunctions After LVAD Implantation

By

Lead malfunctions in implantable cardioverter defibrillators following left ventricular assist device implantation do occur, but may improve over time.

Guideline-Directed Medical Therapy Underused in HFrEF Patients Before ICD

Guideline-Directed Medical Therapy Underused in HFrEF Patients Before ICD

By

Patients with heart failure with reduced ejection fraction who received any guideline-directed medical therapy were less likely to die within 1 year of implantable cardioverter-defibrillator placement.

Decreased Relative Wall Thickness Associated With Ventricular Arrhythmia in Mild Heart Failure

Decreased Relative Wall Thickness Associated With Ventricular Arrhythmia in Mild Heart Failure

By

Cardiac resynchronization therapy with defibrillator therapy was associated with a greater increase in relative wall thickness compared with implantable cardioverter-defibrillator therapy.

LifeVest Wearable Defibrillator for Children FDA Approved

LifeVest Wearable Defibrillator for Children FDA Approved

The LifeVest wearable defibrillator has been approved for children at risk for cardiac arrest but cannot have a defibrillator implanted.

Sign Up for Free e-Newsletters